SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-125067
Filing Date
2023-12-12
Accepted
2023-12-11 18:11:36
Documents
12
Period of Report
2023-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332644d1_8k.htm   iXBRL 8-K 24443
  Complete submission text file 0001104659-23-125067.txt   195492

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mbio-20231211.xsd EX-101.SCH 3021
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbio-20231211_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbio-20231211_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2332644d1_8k_htm.xml XML 3209
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 231479532
SIC: 2834 Pharmaceutical Preparations